The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $162,375 in first-year total cost, median $81,188.
Most frequent study sections
- Addiction Risks and Mechanisms Study Section[ARM]1
- Interventions to Prevent and Treat Addictions Study Section[IPTA]1
Most frequent institutions
- DUKE UNIVERSITY1
- MCLEAN HOSPITAL1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | Targeting orexin to treat nicotine dependence1R03DA048941-01 | JANES, AMY C | MCLEAN HOSPITAL, MA | $82,000 | ARM |
| 2019 | Opioid sparing potential of light-induced analgesia: a pilot trial of a novel, non-pharmacological treatment for pain1R03DA046011-01A1 | GULUR, PADMA | DUKE UNIVERSITY, NC | $80,375 | IPTA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.